<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04363970</url>
  </required_header>
  <id_info>
    <org_study_id>sad2020</org_study_id>
    <nct_id>NCT04363970</nct_id>
  </id_info>
  <brief_title>Early Removal of the Urethral Catheter Following Trans-urethral Resection of Prostate</brief_title>
  <official_title>Early Versus Delayed Removal of the Urethral Catheter After Trans Urethral, Randomized Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Jordan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Jordan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Transurethral resection of prostate is the gold standard operation for bladder outflow
      obstruction due to benign prostatic enlargement. However, catheter removal day is variable.
      The objective of this study is to compare early and delayed catheter removal groups in terms
      of, urinary retention after catheter removal, length of hospital stay, weight of resected
      prostate, duration of resection, peri-operative blood transfusion, and postoperative
      complications.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This randomized controlled trial will carried out in Urology clinic at Jordan university
      hospital. Patients with benign prostate hyperplasia will be selected by simple random
      sampling technique after taking informed consent and will divided into two groups: Group A-
      early catheter removal group( catheter removed after 24 hours) and Group B-delayed catheter
      removal group ( catheter removed after 48 hours). in this study we will exclude patients with
      large post-void urine volume, simultaneous internal urethrotomy and transurethral resection
      of prostate, co-morbidity( diabetes mellitus, CVA) spinal cord injury, urethral stricture,
      prostate cancer proved by biopsy and intra-operative complications. Patients will discharged
      after removal of catheter if they voided successfully.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 30, 2020</start_date>
  <completion_date type="Anticipated">April 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>urinary retention</measure>
    <time_frame>after 3 months.</time_frame>
    <description>inability to void</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lower urinary tract symptoms</measure>
    <time_frame>after 3 months.</time_frame>
    <description>urinary symptoms after the procedure.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Urinary Retention</condition>
  <arm_group>
    <arm_group_label>group A- early catheter removal)</arm_group_label>
    <description>in group A, we will remove the catheter after 24 h.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B- delayed catheter removal</arm_group_label>
    <description>In group B, we will remove the catheter after 48 h.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>removal of the urinary catheter</intervention_name>
    <description>in group A, we will remove the catheter after 24 h. In group B, we will remove the catheter after 48 h.</description>
    <arm_group_label>Group B- delayed catheter removal</arm_group_label>
    <arm_group_label>group A- early catheter removal)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        200 adult males from urology clinic atJordan university hospital, with benign prostate
        hyperplasia who undergo trans-urethral resection of the prostae will be included in this
        study,
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - All men with benign prostate hyperplasia who planned to undergo TURP will be included in
        this study.

        Exclusion Criteria:

          -  Large post void residual urine.

          -  Simultaneous internal urethrotomy and TURP.

          -  Uncontrolled Diabetes Mellitus (DM).

          -  Cerebrovascular accident accident (CVA).

          -  Spinal cord injury.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Saddam Al Demour, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jordan university hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Saddam Al Demour, MD</last_name>
    <phone>+962799144000</phone>
    <email>saldemour@ju.edu.jo</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Saddam Al Demour, MD</last_name>
    <phone>+962798504950</phone>
    <email>saldemour@ju.edu.jo</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Jordan University Hospital</name>
      <address>
        <city>Amman</city>
        <zip>11942</zip>
        <country>Jordan</country>
      </address>
    </facility>
    <contact>
      <last_name>Saddam Al Demour, MD</last_name>
      <phone>+962799144000</phone>
      <email>saldemour@ju.edu.jo</email>
    </contact>
  </location>
  <location_countries>
    <country>Jordan</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>April 16, 2020</study_first_submitted>
  <study_first_submitted_qc>April 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 27, 2020</study_first_posted>
  <last_update_submitted>May 12, 2020</last_update_submitted>
  <last_update_submitted_qc>May 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Jordan</investigator_affiliation>
    <investigator_full_name>Saddam Al Demour</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Benign Prostate Hyperplasia</keyword>
  <keyword>Urinary retention</keyword>
  <keyword>Re-catheterization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Retention</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

